Skip to content

Profound Medical PROF CA — Revenue

Other geography segments

US
$1.62M+4.7%
DE
$150K-33.6%

Similar metrics at other companies

WYF
WYFICA — Revenue
$2.23M+555%
Geospace Technologies Corporation logo
GEOSCA — Revenue
$308K-53.0%
Fortune Brands Innovations logo
FBINCA — Revenue
$86.03M-0.1%
Transcat logo
TRNSCA — Revenue
$4.7M+5.1%
Worthington Steel logo
WSCA — Revenue
$82.7M-15.7%
Euronet Worldwide logo
EEFTCA — Revenue
$16.45M-4.5%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's ca — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's CA — revenue?
Profound Medical (PROF) reported CA — revenue of $3.57M in Q1 2026.
How has Profound Medical's CA — revenue changed year-over-year?
Profound Medical's CA — revenue increased by 319.1% year-over-year, from $852K to $3.57M.
What is the long-term trend for Profound Medical's CA — revenue?
Over 2 years (2023 to 2025), Profound Medical's CA — revenue has grown at a 265.9% compound annual growth rate (CAGR), from $230K to $3.08M.
What does CA — revenue mean?
This metric represents the total gross income generated from the sale of goods and services within the specified geographic segment. It serves as a primary indicator of market penetration and commercial adoption of the company's therapeutic systems in that region.